Form 4 for EW Edwards Lifesciences
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-15 · accession 0001225208-21-012422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| DM | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $121.17 | -32.5K | 188.0K | -15% | -$3.94M |
| D | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 215.6K | -5% | $0 |
| DI | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.20M | +0.4% | $0 |
| D | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -45.0K | 360.4K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | M | A | 45,050 | $21.76 | 233,051.82 | D By Living Trust | — | — | |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 4,983 | $120.53 | 228,068.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $119.9300 to $120.9300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-09-15 | G | D | 12,500 | $0.00 | 215,568.82 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-15 | S | D | 27,567 | $121.29 | 188,001.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $120.9400 to $121.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-09-15 | G | A | 12,500 | $0.00 | 3,197,787 | I | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Acquire) | 2021-09-15 | M | D | 45,050 | $0.00 | 360,400 | D | $21.76 · 2015-06-14 to 2022-05-13 | 45,050 Common Stock |